Celgene Summary
Celgene Corporation, a biopharmaceutical company, engages in the
discovery, development, and commercialization of innovative therapies
to treat cancer and immune-inflammatory related diseases in Europe and
the United States. Its lead products include THALOMID for the treatment
and suppression of cutaneous manifestations of erythema nodosum
leprosum, an inflammatory complication of leprosy.
Executives
Dr. Sol Barer - Chairman, CEO
Robert Hugin - President, COO, Secertary
